GAMMA Investing
KYTX icon

GAMMA Investing’s Kyverna Therapeutics KYTX Stock Holding History

GAMMA Investing’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.84K Buy
+417
New +$3.29K ﹤0.01% 3855

Other funds holding KYTX

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

GAMMA Investing's KYTX Position: Q3 2026 in Review

GAMMA Investing opened a new position in Kyverna Therapeutics (KYTX) in Q3 2026: 417 shares worth $2.84K. The stake represents ﹤0.01% of the portfolio and ranks #3855 among its holdings.

49 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.

  • GAMMA Investing held 417 shares of Kyverna Therapeutics worth $2.84K as of Q3 2026.
  • Kyverna Therapeutics was a new GAMMA Investing position in Q3 2026.
  • Kyverna Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3855 holding.
  • 49 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.